Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| FMC CORPFMC · Entity 4704 | Director | July 16, 2026 | July 17, 2026 |
| QUAKER CHEMICAL CORPKWR · Entity 4278 | Director | February 10, 2026 | February 12, 2026 |
| ROGERS CORPROG · Entity 4438 | Director | May 09, 2019 | May 13, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
FMC CORP
Report date July 16, 2026 · Filed July 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 28,820.191 |
Reported balance
After 2026-07-16 transaction · row 1
1 source rowRow 1 · 2026-07-16 · Grant · Acquired 11 · Balance 28,820.191 F1: These shares were issued pursuant to dividend equivalent rights in connection with vested restricted stock units held by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were issued pursuant to dividend equivalent rights in connection with vested restricted stock units held by the reporting person.
QUAKER CHEMICAL CORP
Report date February 10, 2026 · Filed February 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 78,010 |
Ending reported balance
After 2026-02-10 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-02-10 · Exercise / conversion · Acquired 8,212 · Balance 84,886 Row 2 · 2026-02-10 · Tax withholding · Disposed 6,876 · Balance 78,010 |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $136.64 · Expires 2027-03-30 | Direct | 0 |
Reported balance
After 2026-02-10 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-02-10 · Exercise / conversion · Disposed 8,212 · Balance 0 F1: The options for this grant vested in three annual installments: 8,213 shares on March 30, 2021; 8,213 shares on March 30, 2022; and 8,212 shares on March 30, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: The options for this grant vested in three annual installments: 8,213 shares on March 30, 2021; 8,213 shares on March 30, 2022; and 8,212 shares on March 30, 2023.
ROGERS CORP
Report date May 09, 2019 · Filed May 13, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Capital (Common) StockSEC Table I · non-derivative | Direct | 17,350 |
Reported balance
After 2019-05-09 transaction · row 1
1 source rowRow 1 · 2019-05-09 · Grant · Acquired 850 · Balance 17,350 F1: Represents shares of Rogers Corporation Capital (Common) Stock receivable pursuant to the May 9, 2019 award of deferred stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of Rogers Corporation Capital (Common) Stock receivable pursuant to the May 9, 2019 award of deferred stock units.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Arcadium Lithium plc
Report date March 06, 2025 · Filed March 06, 2025
Section 16 reporting ended · disclosed 2025-03-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-03-06 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2025-03-06 · Disposition to issuer · Disposed 92,061 · Balance 0 F1: Represents shares of common stock of Aracdium Lithium plc ("Arcadium") disposed of pursuant to the Transaction Agreement, dated October 9, 2024, by and among Arcadium, Rio Tinto Western Holdings Limited ("Parent") and Rio Tinto BM Subsidiary Limited ("Buyers") (the "Transaction Agreement"). Pursuant to the Transaction Agreement, at the effective time of the transaction contemplated thereby (the "Effective Time"), each share of Arcadium common stock held by the reporting person was converted automatically into the right to receive $5.85 per share in cash (the "Consideration"). |
| Ordinary SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-03-06 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2025-03-06 · Disposition to issuer · Disposed 40,786 · Balance 0 F2: Pursuant to the Transaction Agreement, at the Effective Time, each award of Arcadium restricted stock units held by the reporting person was canceled in exchange for the right to receive the Consideration in respect of each share of Arcadium common stock subject to such restricted stock unit award as of immediately prior to the Effective Time. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock of Aracdium Lithium plc ("Arcadium") disposed of pursuant to the Transaction Agreement, dated October 9, 2024, by and among Arcadium, Rio Tinto Western Holdings Limited ("Parent") and Rio Tinto BM Subsidiary Limited ("Buyers") (the "Transaction Agreement"). Pursuant to the Transaction Agreement, at the effective time of the transaction contemplated thereby (the "Effective Time"), each share of Arcadium common stock held by the reporting person was converted automatically into the right to receive $5.85 per share in cash (the "Consideration").
F2: Pursuant to the Transaction Agreement, at the Effective Time, each award of Arcadium restricted stock units held by the reporting person was canceled in exchange for the right to receive the Consideration in respect of each share of Arcadium common stock subject to such restricted stock unit award as of immediately prior to the Effective Time.
Livent Corp.
Report date January 04, 2024 · Filed January 08, 2024
Section 16 reporting ended · disclosed 2024-01-08. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-01-04 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2024-01-04 · Disposition to issuer · Disposed 34,475 · Balance 0 F1: Represents the conversion of each share of common stock of the Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), held by the reporting person as of January 4, 2024, into the right to receive a number of validly issued, fully paid and non-assessable ordinary shares of Arcadium Lithium plc ("Arcadium"), par value $1.00 each ("Arcadium Shares") equal to the Merger Exchange Ratio (as defined in the Transaction Agreement, dated as of May 10, 2023, by and between Livent, Allkem Limited ("Allkem"), Lightning-A Merger Sub, Inc. and Arcadium, providing for a combination of Livent and Allkem in a merger of equals transaction (the "Transaction Agreement")). |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-01-04 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2024-01-04 · Disposition to issuer · Disposed 32,875 · Balance 0 F2: Represents the cancellation and conversion of restricted stock units ("Livent RSUs") with respect to shares of Livent Common Stock, held by the reporting person as of January 4, 2024, into an amount of cash equal to (i) the number of shares of Livent Common Stock subject to such Livent RSUs immediately prior to the Effective Time of the merger (as defined in the Transaction Agreement), multiplied by (ii) the higher of (A) the first available closing price of the Merger Consideration (as defined in the Transaction Agreement) and (B) the closing price per share of Livent Common Stock as reported in the New York Stock Exchange, on the last trading day preceding the Closing Date of the merger (as defined in the Transaction Agreement). |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the conversion of each share of common stock of the Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), held by the reporting person as of January 4, 2024, into the right to receive a number of validly issued, fully paid and non-assessable ordinary shares of Arcadium Lithium plc ("Arcadium"), par value $1.00 each ("Arcadium Shares") equal to the Merger Exchange Ratio (as defined in the Transaction Agreement, dated as of May 10, 2023, by and between Livent, Allkem Limited ("Allkem"), Lightning-A Merger Sub, Inc. and Arcadium, providing for a combination of Livent and Allkem in a merger of equals transaction (the "Transaction Agreement")).
F2: Represents the cancellation and conversion of restricted stock units ("Livent RSUs") with respect to shares of Livent Common Stock, held by the reporting person as of January 4, 2024, into an amount of cash equal to (i) the number of shares of Livent Common Stock subject to such Livent RSUs immediately prior to the Effective Time of the merger (as defined in the Transaction Agreement), multiplied by (ii) the higher of (A) the first available closing price of the Merger Consideration (as defined in the Transaction Agreement) and (B) the closing price per share of Livent Common Stock as reported in the New York Stock Exchange, on the last trading day preceding the Closing Date of the merger (as defined in the Transaction Agreement).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 24, 2017 Filed Dec 21, 2017 21:52 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | GiftCommon Stock | 368 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-066815 · doc4.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,025 Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 20:23 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 11,289 | $0.00 Strike: $72.12 | $0.00 |
DisclosureSEC source: 0001209191-17-039470 · doc4.xml · derivative · entry 11 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,578 Underlying: Common Stock · 11,289 shares Expires 2023-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options for this grant vest in three annual installments: 11,289 shares on February 23, 2017; 11,289 shares on February 23, 2018; and 11,289 shares on February 23, 2019. Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 20:23 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,966 | $0.00 Strike: $87.30 | $0.00 |
DisclosureSEC source: 0001209191-17-039470 · doc4.xml · derivative · entry 10 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,965 Underlying: Common Stock · 5,966 shares Expires 2022-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options for this grant vest in three annual installments: 5,966 shares on February 25, 2016; 5,966 shares on February 25, 2017; and 5,965 shares on February 25, 2018. Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 20:23 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,900 | $0.00 Strike: $73.47 | $0.00 |
DisclosureSEC source: 0001209191-17-039470 · doc4.xml · derivative · entry 9 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,900 shares Expires 2021-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options for this grant vested in three annual installments: 5,901 shares on February 27, 2015; 5,900 shares on February 27, 2016; and 5,900 shares on February 27, 2017. Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 20:23 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Tax withholdingCommon Stock | 7,899 | $147.59 | $1,165,813.41 |
DisclosureSEC source: 0001209191-17-039470 · doc4.xml · nonDerivative · entry 6 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,393 Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 20:23 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionCommon Stock | 11,289 | $72.12 | $814,162.68 |
DisclosureSEC source: 0001209191-17-039470 · doc4.xml · nonDerivative · entry 5 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,292 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 20:23 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Tax withholdingCommon Stock | 4,661 | $147.59 | $687,916.99 |
DisclosureSEC source: 0001209191-17-039470 · doc4.xml · nonDerivative · entry 4 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,003 Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 20:23 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionCommon Stock | 5,966 | $87.30 | $520,831.80 |
DisclosureSEC source: 0001209191-17-039470 · doc4.xml · nonDerivative · entry 3 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,664 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 20:23 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Tax withholdingCommon Stock | 4,314 | $147.59 | $636,703.26 |
DisclosureSEC source: 0001209191-17-039470 · doc4.xml · nonDerivative · entry 2 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,698 Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 20:23 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionCommon Stock | 5,900 | $73.47 | $433,473.00 |
DisclosureSEC source: 0001209191-17-039470 · doc4.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,012 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2017 Filed May 8, 2017 20:11 UTC | ROGERS CORP ROG · Entity 4438 | GrantCapital (Common) Stock | 1,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-009304 · doc4.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,300 F1 · shares: Represents shares of Rogers Corporation Capital (Common) Stock receivable pursuant to the May 4, 2017 award of deferred stock units. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 21:58 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | GrantEmployee Stock Option (right to buy) · Derivative | 21,241 | $0.00 Strike: $134.60 | $0.00 |
DisclosureSEC source: 0001209191-17-015950 · doc4.xml · derivative · entry 5 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,241 Underlying: Common Stock · 21,241 shares Expires 2024-02-27 F3 · derivative.exercise_date: Stock options granted to reporting person under the Company's 2016 Long-Term Performance Incentive Plan and exercisable in three consecutive annual installments: 7,081 shares on February 27, 2018; 7,080 shares on February 27, 2019; and 7,080 shares on February 27, 2020. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 21:58 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | GrantCommon Stock | 4,086 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015950 · doc4.xml · nonDerivative · entry 2 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,112 Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 21:58 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Tax withholdingCommon Stock | 2,470 | $134.60 | $332,462.00 |
DisclosureSEC source: 0001209191-17-015950 · doc4.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,026 F1 · shares: Shares surrendered by reporting person to satisfy withholding tax obligation upon vesting of restricted stock granted on February 27, 2014 under the Company's 2011 Long-Term Performance Incentive Plan. Read SEC document |
| November 21, 2016 Filed Nov 23, 2016 21:06 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,966 | $0.00 Strike: $87.30 | $0.00 |
DisclosureSEC source: 0001209191-16-151956 · doc4.xml · derivative · entry 15 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,931 Underlying: Common Stock · 5,966 shares Expires 2022-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options for this grant vest in three annual installments: 5,966 shares on February 25, 2016; 5,966 shares on February 25, 2017; and 5,965 shares on February 25, 2018. Read SEC document |
| November 21, 2016 Filed Nov 23, 2016 21:06 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 11,801 | $0.00 Strike: $73.47 | $0.00 |
DisclosureSEC source: 0001209191-16-151956 · doc4.xml · derivative · entry 14 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,900 Underlying: Common Stock · 11,801 shares Expires 2021-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options for this grant vest in three annual installments: 5,901 shares on February 27, 2015; 5,900 shares on February 27, 2016; and 5,900 shares on February 27, 2017. Read SEC document |
| November 21, 2016 Filed Nov 23, 2016 21:06 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 13,081 | $0.00 Strike: $58.26 | $0.00 |
DisclosureSEC source: 0001209191-16-151956 · doc4.xml · derivative · entry 13 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,081 shares Expires 2020-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options for this grant vested in three annual installments: 4,360 shares on March 5, 2014; 4,360 shares on March 5, 2015; and 4,361 shares on March 5, 2016. Read SEC document |
| November 21, 2016 Filed Nov 23, 2016 21:06 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,078 | $0.00 Strike: $38.13 | $0.00 |
DisclosureSEC source: 0001209191-16-151956 · doc4.xml · derivative · entry 12 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,078 shares Expires 2019-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options for this grant vested in three annual installments: 5,352 shares on March 6, 2013; 5,352 shares on March 6, 2014; and 5,351 shares on March 6, 2015. Read SEC document |
| November 21, 2016 Filed Nov 23, 2016 21:06 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Tax withholdingCommon Stock | 4,907 | $122.50 | $601,107.50 |
DisclosureSEC source: 0001209191-16-151956 · doc4.xml · nonDerivative · entry 10 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,496 Read SEC document |
| November 21, 2016 Filed Nov 23, 2016 21:06 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionCommon Stock | 5,966 | $87.30 | $520,831.80 |
DisclosureSEC source: 0001209191-16-151956 · doc4.xml · nonDerivative · entry 9 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,403 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 21, 2016 Filed Nov 23, 2016 21:06 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Tax withholdingCommon Stock | 9,039 | $122.50 | $1,107,277.50 |
DisclosureSEC source: 0001209191-16-151956 · doc4.xml · nonDerivative · entry 8 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,437 Read SEC document |
| November 21, 2016 Filed Nov 23, 2016 21:06 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionCommon Stock | 11,801 | $73.47 | $867,019.47 |
DisclosureSEC source: 0001209191-16-151956 · doc4.xml · nonDerivative · entry 7 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,476 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 21, 2016 Filed Nov 23, 2016 21:06 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Tax withholdingCommon Stock | 9,027 | $122.50 | $1,105,807.50 |
DisclosureSEC source: 0001209191-16-151956 · doc4.xml · nonDerivative · entry 6 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,675 Read SEC document |
| November 21, 2016 Filed Nov 23, 2016 21:06 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionCommon Stock | 13,081 | $58.26 | $762,099.06 |
DisclosureSEC source: 0001209191-16-151956 · doc4.xml · nonDerivative · entry 5 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 21, 2016 Filed Nov 23, 2016 21:06 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Tax withholdingCommon Stock | 1,943 | $122.50 | $238,017.50 |
DisclosureSEC source: 0001209191-16-151956 · doc4.xml · nonDerivative · entry 4 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,621 Read SEC document |
| November 21, 2016 Filed Nov 23, 2016 21:06 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionCommon Stock | 3,078 | $38.13 | $117,364.14 |
DisclosureSEC source: 0001209191-16-151956 · doc4.xml · nonDerivative · entry 3 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,564 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 20, 2016 Filed Nov 23, 2016 21:06 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | GrantCommon Stock | 308 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-151956 · doc4.xml · nonDerivative · entry 2 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By son Disclosed balance after: 1,980 Read SEC document |
| April 20, 2016 Filed Nov 23, 2016 21:06 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | GiftCommon Stock | 616 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-151956 · doc4.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,486 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.